Intercept to Present at Upcoming Investor Conferences
06 March 2019 - 9:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced that management will be presenting at the following
upcoming investor conferences:
- Cowen 39th Annual Healthcare Conference at 8:00 a.m. ET on
Tuesday, March 12, 2019
- Oppenheimer 29th Annual Healthcare Conference at 11:30 a.m. ET
on Tuesday, March 19, 2019
Webcast information for these events will be available on the
investor page of Intercept’s website at
http://ir.interceptpharma.com. Archived webcasts will be available
on Intercept’s website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). Founded in 2002 in New York, Intercept has
operations in the United States, Europe and Canada.
CONTACT
For more information about Intercept, please contact:
Mark Vignola
+1-646-747-1000
investors@interceptpharma.com
Media
inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2024 to May 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From May 2023 to May 2024